Joseph P. Lucia & Associates’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Joseph P. Lucia & Associates’s Portfolio PBE Stock Details PBE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-638	Closed	-$37K	–	348
2022 Q2	$37K	Hold	638	–	–	0.03%	202
2022 Q1	$40K	Buy	+638	New	+$38.9K	0.02%	207
2021 Q4	–	Sell	-638	Closed	-$48K	–	423
2021 Q3	$48K	Hold	638	–	–	0.03%	220
2021 Q2	$49K	Hold	638	–	–	0.03%	222
2021 Q1	$47K	Hold	638	–	–	0.02%	208
2020 Q4	$45K	Buy	+638	New	+$40.4K	0.03%	192
2020 Q3	–	Sell	-638	Closed	-$37K	–	345
2020 Q2	$37K	Sell	638 -281	-31%	-$15.3K	0.03%	193
2020 Q1	$43K	Sell	919 -379	-29%	-$19.8K	0.05%	164
2019 Q4	$72K	Sell	1,298 -72	-5%	-$3.75K	0.07%	150
2019 Q3	$65K	Sell	1,370 -170	-11%	-$8.71K	0.07%	153
2019 Q2	$82K	Sell	1,540 -11,723	-88%	-$608K	0.09%	131
2019 Q1	$238	Buy	+13,263	New	+$701K	0.02%	209

Other funds holding PBE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GKWIM

Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CreativeOne Wealth Overland Park, Kansas $4.31B AUM 19.42% 1-Year Est. Return

YIA

YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return

IFWM

Institute for Wealth Management Denver, Colorado $938M AUM 29.36% 1-Year Est. Return

Joseph P. Lucia & Associates's PBE Position: Q3 2022 in Review

Joseph P. Lucia & Associates sold out of Invesco Biotechnology & Genome ETF (PBE) in Q3 2022, closing a stake of 638 shares — an estimated $37K sold.

Joseph P. Lucia & Associates first reported a position in PBE in Q1 2019 and held it in 12 quarters. The position peaked at $82K in Q2 2019. 86 funds tracked by Wall St. Rank hold PBE as of Q3 2022.

Joseph P. Lucia & Associates reported no remaining Invesco Biotechnology & Genome ETF position as of Q3 2022 after selling out during the quarter.
Joseph P. Lucia & Associates sold 638 Invesco Biotechnology & Genome ETF shares in Q3 2022, an estimated $37K.
Joseph P. Lucia & Associates first reported a position in Invesco Biotechnology & Genome ETF in Q1 2019 and held it in 12 quarters.
Joseph P. Lucia & Associates's Invesco Biotechnology & Genome ETF position peaked at $82K in Q2 2019.
86 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2022.

Based on Joseph P. Lucia & Associates's 13F filing for Q3 2022, filed 28 Oct 2022.